Analyst Profile
Followed by 88 other investors
Reni Benjamin
JMP Securities
Wall Street Analyst
Ranked #7,796 out of 7,972 Analysts on TipRanks (#21,256 out of 21,851 overall experts)
Success Rate
134 out of 390 Profitable Transactions
Average Return
-8.40%
Average return per transaction
Time Frame
Compare to
If you copied Reni Benjamin's ratings since 2009 and opened each position for the duration of 1 Year:
34.36% of your transactions would have been profitable with an average return of -8.4%
Stock Rating Distribution
81.23% Buy
18.52% Hold
0.24% Sell
Distribution of Reni Benjamin's ratings
Additional Information
Main Sector:Healthcare
Geo Coverage:
US Market
US MarketBest Rating
The most profitable rating made by Reni Benjamin
Reni Benjamin's Stock Coverage
Dendreon Corp
Apr 29, 2009
Buy
Reiterated
―
―
0.00%
1
Sciclone Pharmaceuticals
Mar 31, 2010
Buy
Reiterated
―
―
0.00%
2
Aeterna Zentaris
May 10, 2010
Buy
Reiterated
―
―
0.00%
2
Geron
Oct 12, 2010
Buy
Reiterated
$9.00
(237.08% Upside)
―
0.00%
2
Sarepta Therapeutics
Jul 24, 2013
Hold
Downgraded
$39.00
(-66.94% Downside)
―
0.00%
1
KBR
May 05, 2014
Buy
Initiated
$17.00
(-64.49% Downside)
―
0.00%
1
Palisade Bio
Oct 13, 2014
Hold
Reiterated
―
―
0.00%
3
Pharmacyclics
Oct 27, 2014
Buy
Initiated
―
―
0.00%
1
OncoSec Medical
Dec 11, 2014
Buy
Reiterated
$40.00
(5914.13% Upside)
―
0.00%
6
Agenus
Jan 09, 2015
Buy
Reiterated
$6.00
(129.45% Upside)
―
0.00%
6
List of latest recommendations made by Reni Benjamin. Click to expand and see Reni Benjamin's performance on a particular stock
Disclaimer: TipRanks collects ratings and price targets of analysts by scanning publicly available reports on financial websites and by receiving reports directly from the analysts or from our users. The information displayed and the Analyst Profile statistics might not be accurate, complete, or up to date. The analyst ratings provided are entirely at the sole responsibility of the of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings or opinions expressed on the site.
Are We Missing a Rating?
Send us the equity research you are getting and become a Power User
Learn More